Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: Is there a role for curcumin?

Folia Neuropathologica

Volumn 53, Issue 2, 2015, Pages 89-99

  Pluta, Ryszard ^a   Bogucka Kocka, Anna ^b   Ułamek Kozioł, Marzena ^a   Furmaga Jabłońska, Wanda ^b   Januszewski, Sławomir ^a   Brzozowska, Judyta ^b   Jabłoński, Mirosław ^b   Kocki, Janusz ^b  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Brain ischemia; Curcumin; Dementia; Neurodegeneration; Neurogenesis; Neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN; CURCUMIN; TAU PROTEIN; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; COGNITION; DIETARY INTAKE; DRUG EFFECT; DRUG POTENCY; HIPPOCAMPUS; HUMAN; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; REVIEW; ANIMAL; BRAIN; COMPLICATION; DRUG EFFECTS; PATHOLOGY; PHENOTYPE;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN ISCHEMIA; CURCUMIN; HUMANS; NERVE DEGENERATION; NEUROGENESIS; NEUROPROTECTIVE AGENTS; PHENOTYPE;

EID: 84934763813     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2015.52405     Document Type: Review

References (77)

1. Albarracin SL, Stab B, Casas Z, Sutachan JJ, Samudio I, Gonzalez J, Gonzalo L, Capani F, Morales L, Barreto GE. Effects of natural antioxidants in neurodegenerative diseases. Nutr Neurosci 2012; 15: 1-9.
2. Allen E. The cessation of mitosis in the central nervous system of the albino rat. J Comp Neurol 1912; 22: 547-568.
3. Barra de la Tremblaye P, Plamondon H. Impaired conditioned emotional response and object recognition are concomitant to neuronal damage in the amygdale and perirhinal cortex in middle-aged ischemic rats. Behav Brain Res 2011; 219: 227-233.
4. Basli A, Soulet S, Chaher N, Mérillon JM, Chibane M, Monti JP, Richard T. Wine polyphenols: potential agents in neuroprotection. Oxid Med Cell Longev 2012; Article ID 805762.
5. Biscaro B, Lindvall O, Tesco G, Ekdahl CT, Nitsch RM. Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease. Neurodegener Dis 2012; 9: 187-198.
6. Burbach GJ, Hellweg R, Haas CA, Del Turco D, Deicke U, Abramowski D, Jucker M, Staufenbiel M, Deller T. Induction of brain-derived neurotrophic factor in plaque associated glial cells of aged APP23 transgenic mice. J Neurosci 2004; 24: 2421-2430.
7. Choi SH, Veeraraghavalu K, Lazarov O, Marler S, Ransohoff RM, Ramirez JM, Sisodia SS. Non-cell autonomous effects of presenilin 1 variants on enrichment mediated hippocampal progenitor cell proliferation and differentiation. Neuron 2008; 59: 568-580.
8. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I. Regulation of SIRT1 in cellular functions: Role of polyphenols. Arch Biochem Biophys 2010; 501: 79-90.
9. Curtis MA, Kam M, Nannmark U, Anderson MF, Axell MZ, Wikkelso C, Holtås S, van Roon-Mom WM, Björk-Eriksson T, Nordborg C, Frisén J, Dragunow M, Faull RL, Eriksson PS. Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science 2007; 315: 1243-1249.
10. Deng W, Aimone JB, Gage FH. New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat Rev Neurosci 2010; 11: 339-350.
11. Dias GP, Cavegn N, Nix A, Do Nascimento Bevilaqua MC, Stangl D, Zainuddin MS, Nardi AE, Gardino PF, Thuret S. The role of dietary polyphenols on adult hippocampal neurogenesis: Molecular mechanisms and behavioural effects on depression and anxiety. Oxid Med Cell Longev 2012; 2012: 541971.
12. Dong S, Zeng Q, Mitchell ES, Xiu J, Duan Y, Li Ch, Tiwari JK, Hu Y, Cao X, Zhao Z. Curcumin enhances neurogenesis and cognition in aged rats: Implications for transcriptional interactions related to growth and synaptic plasticity. PLos ONE 2012; 7: e31211.
13. Estabeyoglu T, Huebbe P, Ernst IMA, Chin D, Wagner AE, Rimbach G. Curcumin-From molecule to biological function. Angew Rev Int Ed 2012; 51: 5308-5332.
14. Faria A, Pestana D, Teixeira D, Azevedo J, De Freitas V, Mateus N, Calhau C. Flavonoid transport across RBE4 cells: a blood-brain barrier model. Cell Mol Biol Lett 2010; 15: 234-241.
15. Flynn RWV, MacWalter RSM, Doney ASF. The cost of cerebral ischemia. Neuropharmacology 2008; 55: 250-256.
16. Frautschy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, Cole GM. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 2001; 22: 993-1005.
17. Haile WB, Wu J, Echeverry R, Wu F, An J, Yepes M. Tissue type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α. JCBFM 2012; 32: 57-59.
18. Hung CW, Chen YC, Hsieh WL, Chiou SH, Kao CL. Ageing and neurodegenerative diseases. Ageing Res Rev 2010; 9: S36-S46.
19. Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM, Ahmad A, Islam F. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur Neuropsychopharm 2009; 19: 636-647.
20. Jiang J, Wang W, Sun YJ, Hu M, Li F, Zhu DY. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur J Pharmacol 2007; 561: 54-62.
21. Jones QR, Warford J, Rupasinghe HPV, Robertson GS. Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol Sci 2012; 33: 602-610.
22. Kernie SG, Parent JM. Forebrain neurogenesis after focal ischemic and traumatic brain injury. Neurobiol Dis 2010; 37: 267-274.
23. Kim SJ, Son TG, Park HR, Park M, Kim M-S, Kim HS, Chung HY, Mattson MP, Lee J. Curcumin stimulates proliferation of embryonic neuronal progenitor cells and neurogenesis in the adult hippocampus. J Biol Chem 2008; 283: 14497-14505.
24. Kiryk A, Pluta R, Figiel I, Mikosz M, Ułamek M, Niewiadomska G, Jabłoński M, Kaczmarek L. Transient brain ischemia due to cardiac arrest causes irreversible long-lasting cognitive injury. Behav Brain Res 2011; 219: 1-7.
25. Knoth R, Singec I, Ditter M, Pantazis G, Capetian P, Meyer RP, Horvat V, Volk B, Kempermann G. Murine features of neurogenesis in the human hippocampus across the lifespan from 0 to 100 years. PLoS One 2010; 5: e8809.
26. Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J Neurosci 1996; 16: 2027-2033.
27. Lazarov O, Marr RA. Neurogenesis and Alzheimer's disease: At the crossroads. Exp Neurol 2010; 223: 267-281.
28. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005; 4: 752-759.
29. Li J, Wang YJ, Zhang M, Fang CQ, Zhou HD. Cerebral ischemia aggravates cognitive impairment in a rat model of Alzheimer's disease. Life Sci 2011; 89: 86-92.
30. Lichtenwalner RJ, Parent JM. Adult neurogenesis and the ischemic forebrain. JCBFM 2006; 26: 1-20.
31. Lindvall O, Kokaia Z. Stem cell research in stroke: how far from the clinic? Stroke 2011; 42: 2369-2375.
32. Lopez-Toledano MA, Ali Faghihi M, Patel NS, Wahlestedt C. Adult neurogenesis: A potential tool for early diagnosis in Alzheimer's disease? J Alzheimers Dis 2010; 20: 395-408.
33. Luheshi NM, Kovacs KJ, Lopez-Castejon G, Brough D, Denes A. Interleukin-1α expression precedes IL-1β after ischemic brain injury and is localized to area of focal neuronal loss and penumbral tissues. J Neuroinflamm 2011; 29: 186.
34. Ma QL, Zuo X, Yang F, Ubeda OJ, Gant DJ, Alaverdyan M, Teng E, Hu S, Chen PP, Maiti P, Teter B, Cole GM, Frautschy SA. Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J Biol Chem 2013; 288: 4056-4065.
35. Menezea AR, Lavie CJ, Milani RV, Okeefe J. The effects of statins on prevention of stroke and dementia: a review. Psychosomatics 2012; 32: 240-249.
36. Molina CA. Reperfusion therapies for acute ischemic stroke: current pharmacological and mechanical approaches. Stroke 2011; 42: 16-19.
37. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jonsson B. The economic cost of brain disorders in Europe. Eur J Neurol 2012; 19: 155-162.
38. Paizanis E, Kelai S, Renoir T, Hamon M, Lanfumey L. Life-long hippocampal neurogenesis: Environmental, pharmacological and neurochemical modulations. Neurochem Res 2007; 32: 1762-1771.
39. Park HR, Lee J. Neurogenic contributions made by dietary regulation to hippocampal neurogenesis. Ann N Y Acad Sci 2011; 1229: 23-28.
40. Perez-Jimenez J, Neveu V, Vos F, Scalbert A. Identification of the 100 richest dietary sources of polyphenols: an application of the Phenol-Explorer database. Eur J Clin Nutr 2010; 64: 112-120.
41. Pinkston JB, Alekseeva N, Gonzalez Toledo E. Stroke and dementia. Neurol Res 2009; 31: 824-831.
42. Pluta R. Influence of prostacyclin on early morphological changes in the rabbit brain after complete 20-min ischemia. J Neurol Sci 1985; 70: 305-316.
43. Pluta R. Astroglial expression of the beta-amyloid in ischemia reperfusion brain injury. Ann N Y Acad Sci 2002; 977: 102-108.
44. Pluta R, Ułamek M, Januszewski S. Micro-blood-brain barrier openings and cytotoxic fragments of amyloid precursor protein accumulation in white matter after ischemic brain injury in long-lived rats. Acta Neurochir (Suppl) 2006; 96: 267-271.
45. Pluta R, Januszewski S, Ułamek M. Ischemic blood-brain barrier and amyloid in white matter as etiological factors in leukoaraiosis. Acta Neurochir (Suppl) 2008; 102: 353-356.
46. Pluta R, Ułamek M, Jabłoński M. Alzheimer's mechanisms in ischemic brain degeneration. Anat Rec 2009; 292: 1863-1881.
47. Pluta R, Januszewski S, Jabłoński M, Ułamek M. Factors in creepy delayed neuronal death in hippocampus following brain ischemia-reperfusion injury with long-term survival. Acta Neurochir (Suppl) 2010; 106: 37-41.
48. Pluta R, Ułamek M, Jabłoński M. Consideration of the ischaemic basis and treatment of Alzheimer's disease. Folia Neuropathol 2010; 48: 11-26.
49. Pluta R, Furmaga-Jabłońska W, Jabłoński M. Therapeutic food benefits after ischemic brain edema. Nutrition 2012; 28: 1192-1193.
50. Pluta R, Jabłoński M, Czuczwar SJ. Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide. Folia Neuropathol 2012; 50: 101-109.
51. Pluta R, Kocki J, Maciejewski R, Ułamek-Kozioł M, Jabłoński M, Bogucka-Kocka A, Czuczwar SJ. Ischemia signaling to Alzheimer-related genes. Folia Neuropathol 2012; 50: 322-329.
52. Pluta R, Furmaga-Jabłońska W, Maciejewski R, Ułamek-Kozioł M, Jabłoński M. Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: Significance in sporadic Alzheimer's disease. Mol Neurobiol 2013; 47: 425-434.
53. Pluta R, Jabłoński M, Ułamek-Kozioł M, Kocki J, Brzozowska J, Januszewski S, Furmaga-Jabłońska W, Bogucka-Kocka A, Maciejewski R, Czuczwar SJ. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes. Mol Neurobiol 2013; 48: 500-515.
54. Popa-Wagner A, Buga AM, Kokaia Z. Perturbed cellular response to brain injury during aging. Ageing Res Rev 2011; 10: 71-79.
55. Qi J, Wu H, Yang Y, Wand D, Chen Y, Gu Y, Liu T. Cerebral ischemia and Alzheimer's disease: the expression of amyloid-β and apolipoprotein E in human hippocampus. J Alzheimers Dis 2007; 12: 335-341.
56. Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr 2011; 6: 93-108.
57. Saver JL. Time is brain - quantified. Stroke 2006; 37: 263-266.
58. Sekeljic V, Bataveljic D, Stamenkovic S, Ułamek M, Jabłoński M, Radenovic L, Pluta R, Andjus PR. Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model. Brain Struct Funct 2012; 217: 411-420.
59. Stangl D, Thuret S. Impact of diet on adult hippocampal neurogenesis. Genes Nutr 2009; 4: 271-282.
60. Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, Kumar P. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging 2002; 23: 237-243.
61. Thilakarathna SH, Rupasinghe HPV, Needs APW. Apple peel bioactive rich extracts effectively inhibit in vitro human LDL oxidation. Food Chem 2013; 138: 463-470.
62. Thiyagarajan M, Sharma SS. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci 2004; 74: 969-985.
63. Tiwari SK, Agrawal S, Seth B, Yadav A, Nair S, Bhatnagar P, Karmakar M, Kumari M, Chauhan LKS, Patel DK, Srivastava V, Singh D, Gupta SK, Tripathi A, Chaturvedi RK, Gupta KCh. Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer's disease model via canonical Wnt/β-catenin pathway. ACSNANO 2014; 8: 76-103.
64. Tuttolomondo A, Di Raimondo D, Di Sciacca R, Pinto A, Licata G. Inflammatory cytokines in acute ischemic stroke. Curr Pharm Design 2008; 14: 3574-3589.
65. Ułamek-Kozioł M, Furmaga-Jabłońska W, Januszewski S, Brzozowska J, ͆ciślewska M, Jabłoński M, Pluta R. Neuronal autophagy: self-eating or self-cannibalism in Alzheimer's disease. Neurochm Res 2013; 38: 1769-1773.
66. Wang Q, Sun AY, Simonyi A, Jensen M, Shelat PB, Rottinghaus GE, MacDonald RS, Miller DK, Lubahn DE, Weisman GA, Sun GY. Neuroprtective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J Neurosci Res 2005; 82: 138-148.
67. Wang Y, Yin H, Wang L, Shuboy A, Lou J, Han B, Zhang X, Li J. Curcumin as a potential treatment for Alzheimer's disease: A study of the effects of curcumin on hippocampal expression of glial fibrillary acidic protein. Am J Chin Med 2013; 41: 59-70.
68. Wen Y, Yang SH, Liu R, Perez EJ, Brun-Ziukemagel AM, Koulen P, Simpkins JW. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 2007; 1772: 473-483.
69. Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, Ogle WO. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res 2007; 1162: 9-18.
70. Yang SH, Simpkins JW. Ischemia-reperfusion promotes tau and beta-amyloid pathology and a progressive cognitive impairment. In Pluta R, editor. Ischemia-reperfusion pathways in Alzheimer's disease. Nova Science Publishers, Inc., New York 2007, pp. 113-138.
71. Zainuddin MSA, Thuret S. Nutrition, adult hippocampal neurogenesis and mental health. Br Med Bull 2012; 103: 89-114.
72. Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, Schneider A, Schwaninger M. Neuronal activation of NF-κB contributes to cell death in cerebral ischemia. JCBFM 2005; 25: 30-40.
73. Zhao C, Deng W, Gage FH. Mechanisms and functional implications of adult neurogenesis. Cell 2008; 132: 645-660.
74. Zhao J, Zhao Y, Zheng W, Lu Y, Feng G, Yu S. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res 2008; 1229: 224-232.
75. Zhao J, Yu S, Zheng W, Feng G, Luo G, Wang L, Zhao Y. Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochem Res 2010; 35: 374-379.
76. Zheng M, Liu J, Ruan Z, Tian S, Ma Y, Zhu J, Li G. Intrahippocampal injection of Abeta(1-42) inhibits neurogenesis and down-regulates IFN-gamma and NF-kappaB expression in hippocampus of adult mouse brain. Amyloid 2013; 20: 13-20.
77. Zhu DY, Lau L, Wei JS, Liu SH, Lu YM. Activation of cAMP-respose-element-binding protein (CREB) after focal cerebral ischemia stimulates neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci USA 2004; 101: 9453-9457.